Zevra Therapeutics (ZVRA) Inventory (2024 - 2026)

Zevra Therapeutics' Inventory history runs 3 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• Quarterly Inventory fell 9.73% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 9.73% YoY) and the FY2025 annual result came in at $1.7 million, down 11.68% from the prior year.
• Inventory was $2.3 million for Q1 2026 at Zevra Therapeutics, up from $1.7 million in the prior quarter.
• Across five years, Inventory topped out at $2.6 million in Q1 2025 and bottomed at $1.1 million in Q2 2025.
• A 3-year average of $1.8 million and a median of $1.9 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2025 — Inventory dropped 11.68% — and 2026, when it fell 9.73%.
• Zevra Therapeutics' Inventory stood at $2.0 million in 2024, then slipped by 11.68% to $1.7 million in 2025, then jumped by 32.76% to $2.3 million in 2026.
• Business Quant data shows ZVRA's Inventory at $2.3 million in Q1 2026, $1.7 million in Q4 2025, and $1.4 million in Q3 2025.